MANILA (Reuters) - The Philippines has fined Sanofi $2,000 and suspended clearance for the French drug maker's controversial dengue vaccine Dengvaxia, citing violations on product registration and marketing, its health secretary said on Thursday.
Original Article: Philippines fines Sanofi, suspends clearance for Dengvaxia
NEXT ARTICLE